Deciphera Pharmaceuticals Inc (DCPH.OQ)
DCPH.OQ on NASDAQ Stock Exchange Global Select Market
24.74USD
17 Dec 2018
24.74USD
17 Dec 2018
Change (% chg)
-- (--)
-- (--)
Prev Close
$24.74
$24.74
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
73,239
73,239
52-wk High
$45.61
$45.61
52-wk Low
$16.22
$16.22
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Sep '18 | 0.00 | -0.649 |
| Jun '18 | 0.00 | -0.646 | |
| Mar '18 | 0.00 | -0.657 | |
| FY 2017 | Dec '17 | 0.00 | -0.649 |
| Sep '17 | 0.00 | -0.392 | |
| Jun '17 | 0.00 | -0.346 | |
| Mar '17 | 0.00 | -0.251 | |
| FY 2016 | Dec '16 | 0.00 | -0.279 |
| Sep '16 | 0.00 | -2.964 | |
| Jun '16 | 0.00 | -0.193 | |
| Mar '16 | 0.00 | -0.174 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-18 | 11 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Mar-19 | 7 | 0.00 | 0.00 | 0.00 | -- |
| Year Ending Dec-18 | 11 | 0.00 | 0.00 | 0.00 | 0.00 |
| Year Ending Dec-19 | 11 | 9.09 | 100.00 | 0.00 | 25.00 |
| Earnings (per share) | |||||
| Quarter Ending Dec-18 | 11 | -0.72 | -0.60 | -0.82 | -0.54 |
| Quarter Ending Mar-19 | 5 | -0.76 | -0.62 | -0.87 | -- |
| Year Ending Dec-18 | 11 | -2.67 | -2.55 | -2.80 | -2.19 |
| Year Ending Dec-19 | 11 | -2.87 | -0.29 | -3.67 | -2.45 |
| LT Growth Rate (%) | 1 | 21.00 | 21.00 | 21.00 | -- |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 69.72 | 34.40 | |
| P/E High - Last 5 Yrs. | -- | 148.04 | 46.21 | |
| P/E Low - Last 5 Yrs. | -- | 47.80 | 24.59 | |
| Beta | -- | 1.08 | 0.91 | |
| Price to Sales (TTM) | -- | 49.54 | 6.22 | |
| Price to Book (MRQ) | -- | 10.17 | 5.20 | |
| Price to Tangible Book (MRQ) | 8.04 | 13.82 | 6.74 | |
| Price to Cash Flow (TTM) | -- | 52.81 | 24.17 | |
| % Owned Institutions | -- | 3.75 | 1.77 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.12 | 1.44 | |
| Dividend Yield - 5 Year Avg | -- | 0.09 | 1.46 | |
| Dividend 5 Year Growth Rate | -- | 0.79 | 4.94 | |
| Payout Ratio(TTM) | -- | 7.05 | 42.49 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -- | 129.94 | 8.17 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -- | 47.86 | 6.50 | |
| Sales - 5 Yr. Growth Rate | -- | 22.77 | 10.44 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -79.11 | 75.89 | 23.27 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -- | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 12.03 | 10.50 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 9.25 | 14.59 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.18 | 2.28 |
| Current Ratio (MRQ) | 11.53 | 3.43 | 3.10 |
| LT Debt to Equity (MRQ) | 1.59 | 18.73 | 11.49 |
| Total Debt to Equity (MRQ) | 1.80 | 31.43 | 16.03 |
| Interest Coverage (TTM) | -- | -43.28 | 30.57 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 56.35 | 54.44 | |
| Gross Margin - 5 Yr. Avg. | -- | 60.59 | 52.36 | |
| EBITD Margin (TTM) | -- | -- | -- | |
| EBITD - 5 Yr. Avg | -- | -109.93 | 13.16 | |
| Operating Margin (TTM) | -- | -184.87 | 6.07 | |
| Operating Margin - 5 Yr. Avg. | -- | -126.36 | 8.47 | |
| Pre-Tax Margin (TTM) | -- | -175.63 | 7.02 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | -132.51 | 8.71 | |
| Net Profit Margin (TTM) | -- | -182.37 | 3.12 | |
| Net Profit Margin - 5 Yr. Avg. | -- | -136.91 | 4.90 | |
| Effective Tax Rate (TTM) | -- | 21.48 | 23.26 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 15.58 | 23.84 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | -- | 7,652,294 | 873,073,486 | |
| Net Income/Employee (TTM) | -- | 652,908 | 103,486,338 | |
| Receivable Turnover (TTM) | -- | 6.25 | 5.80 | |
| Inventory Turnover (TTM) | -- | 1.89 | 3.56 | |
| Asset Turnover (TTM) | -- | 0.32 | 0.95 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -- | 6.46 | 11.45 | |
| Return on Assets - 5 Yr. Avg. | -- | 5.53 | 12.50 | |
| Return on Investment (TTM) | -- | 9.00 | 14.96 | |
| Return on Investment - 5 Yr. Avg. | -- | 6.86 | 16.23 | |
| Return on Equity (TTM) | -- | 10.14 | 16.53 | |
| Return on Equity - 5 Yr. Avg. | -- | 8.39 | 17.37 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -- | -- | -- |
| EPS (TTM) % | -30.90 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Deciphera Pharmaceuticals Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -- | -- | -- | 98 |
| 13 Week | -- | -- | -- | 94 |
| 26 Week | -- | -- | -- | 98 |
| 52 Week | -- | -- | -- | 68 |
| YTD | -- | -- | -- | 72 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 56.01% |
| # of Holders: | 121 |
| Total Shares Held: | 21,094,706 |
| 3 Mo. Net Change: | 478,103 |
| # New Positions: | 20 |
| # Closed Positions: | 19 |
| # Increased Positions: | 63 |
| # Reduced Positions: | 49 |
| # Net Buyers: | 14 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.